News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
81,662 Results
Type
Article (2073)
Company Profile (84)
Press Release (79505)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (32069)
Career Advice (50)
Deals (4997)
Drug Delivery (6)
Drug Development (8026)
Employer Resources (9)
FDA (1518)
Job Trends (2004)
News (44751)
Policy (2573)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (126)
Accelerated approval (10)
Adcomms (1)
Allergies (35)
Alliances (2688)
ALS (40)
Alzheimer's disease (311)
Antibody-drug conjugate (ADC) (109)
Approvals (1743)
Artificial intelligence (193)
Autoimmune disease (56)
Automation (21)
Bankruptcy (17)
Best Places to Work (2060)
Biosimilars (57)
Biotechnology (47)
Bladder cancer (100)
Brain cancer (11)
Breast cancer (299)
Cancer (1911)
Cardiovascular disease (130)
Career advice (50)
Career pathing (3)
CAR-T (67)
CDC (2)
Cell therapy (204)
Cervical cancer (16)
Clinical research (9092)
Collaboration (641)
Compensation (417)
Complete response letters (6)
COVID-19 (204)
CRISPR (34)
C-suite (269)
Cystic fibrosis (34)
Data (2263)
Depression (27)
Diabetes (124)
Diagnostics (940)
Digital health (13)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (77)
Drug pricing (14)
Drug shortages (1)
Duchenne muscular dystrophy (63)
Earnings (31370)
Editorial (2)
Employer branding (1)
Employer resources (9)
Events (9574)
Executive appointments (373)
FDA (2745)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (11)
Funding (528)
Gene editing (65)
Generative AI (7)
Gene therapy (147)
GLP-1 (162)
Government (353)
Grass and pollen (3)
Guidances (307)
Healthcare (2388)
HIV (37)
Huntington's disease (9)
IgA nephropathy (35)
Immunology and inflammation (36)
Immuno-oncology (14)
Indications (48)
Infectious disease (285)
Inflammatory bowel disease (39)
Inflation Reduction Act (2)
Influenza (31)
Intellectual property (60)
Interviews (6)
IPO (3899)
IRA (1)
Job creations (209)
Job search strategy (43)
JPM (1)
Kidney cancer (7)
Labor market (14)
Layoffs (35)
Leadership (1)
Legal (396)
Liver cancer (21)
Longevity (4)
Lung cancer (292)
Lymphoma (158)
Machine learning (15)
Management (2)
Manufacturing (193)
MASH (39)
Medical device (1905)
Medtech (1922)
Mergers & acquisitions (1496)
Metabolic disorders (273)
mRNA (4)
Multiple sclerosis (43)
NASH (3)
Neurodegenerative disease (97)
Neuropsychiatric disorders (20)
Neuroscience (640)
NextGen: Class of 2026 (542)
Non-profit (300)
Now hiring (6)
Obesity (100)
Opinion (10)
Ovarian cancer (59)
Pain (38)
Pancreatic cancer (56)
Parkinson's disease (73)
Partnered (1)
Patents (113)
Patient recruitment (151)
Peanut (15)
People (2836)
Pharmaceutical (20)
Pharmacy benefit managers (3)
Phase 1 (2158)
Phase 2 (3475)
Phase 3 (4052)
Pipeline (2689)
Policy (7)
Postmarket research (344)
Preclinical (702)
Press Release (2)
Prostate cancer (111)
Psychedelics (2)
Radiopharmaceuticals (35)
Rare diseases (227)
Real estate (258)
Recruiting (3)
Regulatory (2888)
Reports (7)
Research institute (143)
Resumes & cover letters (4)
Rett syndrome (20)
RNA editing (1)
RSV (28)
Schizophrenia (41)
Series A (83)
Series B (77)
Service/supplier (1)
Sickle cell disease (26)
Special edition (1)
Spinal muscular atrophy (12)
Sponsored (3)
Startups (136)
Stomach cancer (1)
Supply chain (31)
The Weekly (1)
Vaccines (147)
Venture capital (13)
Weight loss (51)
Women's health (28)
Worklife (2)
Date
Today (59)
Last 7 days (355)
Last 30 days (1018)
Last 365 days (10972)
2026 (1749)
2025 (11162)
2024 (7608)
2023 (5843)
2022 (6767)
2021 (7109)
2020 (6282)
2019 (4804)
2018 (3479)
2017 (3044)
2016 (2473)
2015 (3124)
2014 (2169)
2013 (1425)
2012 (1468)
2011 (2204)
2010 (1694)
Location
Africa (50)
Alabama (12)
Alaska (1)
Arizona (34)
Arkansas (5)
Asia (4360)
Australia (598)
California (4478)
Canada (863)
China (275)
Colorado (173)
Connecticut (238)
Delaware (209)
Europe (11412)
Florida (462)
Georgia (96)
Hawaii (3)
Idaho (6)
Illinois (353)
India (19)
Indiana (131)
Iowa (7)
Japan (229)
Kansas (21)
Kentucky (10)
Louisiana (13)
Maine (18)
Maryland (377)
Massachusetts (3167)
Michigan (93)
Minnesota (233)
Mississippi (3)
Missouri (44)
Montana (4)
Nebraska (3)
Nevada (41)
New Hampshire (24)
New Jersey (1172)
New Mexico (4)
New York (1015)
North Carolina (478)
North Dakota (2)
Northern California (2145)
Ohio (104)
Oklahoma (4)
Oregon (6)
Pennsylvania (664)
Puerto Rico (3)
Rhode Island (9)
South America (85)
South Carolina (4)
Southern California (1683)
Tennessee (66)
Texas (637)
United States (14587)
Utah (94)
Virginia (102)
Washington D.C. (20)
Washington State (383)
West Virginia (1)
Wisconsin (89)
81,662 Results for "39".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aerska Raises $39M Series A Financing led by EQT Dementia Fund and age1 to Systemically Deliver RNA Medicines to the Brain
February 9, 2026
·
2 min read
Press Releases
AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
January 14, 2026
·
4 min read
Press Releases
SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39
January 12, 2026
·
3 min read
Press Releases
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations
February 24, 2026
·
2 min read
Press Releases
Palvella Therapeutics Announces Positive Topline Results from Phase 3 SELVA Clinical Study of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations
February 24, 2026
·
14 min read
Press Releases
Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas
December 16, 2025
·
7 min read
Press Releases
U.S. Single-use Bioprocessing Market Size to Hit USD 39.24 Billion by 2034
November 4, 2025
·
1 min read
Press Releases
Nanotechnology Market Size Expected to Hit USD 116.39 Billion by 2034
August 29, 2025
·
1 min read
Press Releases
High Potency Active Pharmaceutical Ingredients Market Poised for Growth, Expected to Hit USD 71.39 Billion by 2032-Coherent Market Insights
November 3, 2025
·
1 min read
Press Releases
Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025
October 20, 2025
·
7 min read
1 of 8,167
Next
